全文获取类型
收费全文 | 1107篇 |
免费 | 61篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 87篇 |
妇产科学 | 10篇 |
基础医学 | 101篇 |
口腔科学 | 25篇 |
临床医学 | 135篇 |
内科学 | 219篇 |
皮肤病学 | 19篇 |
神经病学 | 51篇 |
特种医学 | 305篇 |
外科学 | 65篇 |
综合类 | 10篇 |
预防医学 | 31篇 |
眼科学 | 6篇 |
药学 | 51篇 |
肿瘤学 | 62篇 |
出版年
2021年 | 8篇 |
2020年 | 4篇 |
2019年 | 5篇 |
2018年 | 14篇 |
2017年 | 3篇 |
2016年 | 8篇 |
2015年 | 15篇 |
2014年 | 19篇 |
2013年 | 28篇 |
2012年 | 13篇 |
2011年 | 20篇 |
2010年 | 33篇 |
2009年 | 28篇 |
2008年 | 18篇 |
2007年 | 34篇 |
2006年 | 22篇 |
2005年 | 24篇 |
2004年 | 23篇 |
2003年 | 12篇 |
2002年 | 12篇 |
2001年 | 10篇 |
2000年 | 9篇 |
1999年 | 21篇 |
1998年 | 96篇 |
1997年 | 70篇 |
1996年 | 77篇 |
1995年 | 52篇 |
1994年 | 54篇 |
1993年 | 62篇 |
1992年 | 11篇 |
1991年 | 9篇 |
1990年 | 14篇 |
1989年 | 41篇 |
1988年 | 26篇 |
1987年 | 38篇 |
1986年 | 24篇 |
1985年 | 29篇 |
1984年 | 23篇 |
1983年 | 16篇 |
1982年 | 22篇 |
1981年 | 23篇 |
1980年 | 28篇 |
1979年 | 6篇 |
1978年 | 16篇 |
1977年 | 18篇 |
1976年 | 20篇 |
1975年 | 13篇 |
1933年 | 1篇 |
1932年 | 1篇 |
1930年 | 1篇 |
排序方式: 共有1179条查询结果,搜索用时 78 毫秒
1.
Needle-localized breast biopsy: why do we fail? 总被引:10,自引:0,他引:10
2.
Ketai LH; Williamson MR; Telepak RJ; Levy H; Koster FT; Nolte KB; Allen SE 《Radiology》1994,191(3):665
3.
4.
荧光原位杂交技术分析人结肠菌群方法研究 总被引:2,自引:0,他引:2
建立荧光原位杂交技术分析人体内结肠菌群的方法。取受试者新鲜粪便 ,选用 5种特异性的 16SrRNA寡核苷酸探针 ,检测粪便样本收集后的保存时间、温度 ,离心条件及样本固定液存放时间对杂交计数结果的影响。结果建立最佳实验条件为 :粪便样本收集后应尽快在 4℃下保存 ,放置时间不要超过 12小时即作处理 ;样本的适宜离心条件为 70 0g 2分钟 ;样本用多聚甲醛固定后在 - 80℃下存放时间不要超过 5个月。该方法具有较好的稳定性 ,可以有效地检出个体之间结肠菌群的差异。 相似文献
5.
6.
The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia 总被引:1,自引:0,他引:1
H Behrendt E F van Leeuwen C Schuwirth R J Verkes J Hermans A van der Does-van den Berg E R van Wering 《Cancer》1989,63(10):2066-2072
In a retrospective study, which comprised the whole Dutch childhood population of approximately 3 million children, the authors assessed the influence of an isolated meningeal relapse, occurring as first relapse, together with some patient and treatment characteristics on prognosis in 142 children with acute lymphoblastic leukemia (ALL). Until their first relapse, patients were initially treated according to standard protocols, whereas the treatment for relapse was heterogeneous. Concerning the probability of achieving a second complete remission (CR) it appears that the duration of the first CR is the single most important prognostic factor. The duration of the first CR is also the most important factor with regard to the duration of the second CR, upon which also age and sex have a significant influence. Concerning the survival from the time of central nervous system (CNS) relapse, again the duration of the first CR appears to be the most important prognostic factor, followed by age and the institution of systemic reinduction treatment. Other factors, such as initial leukocyte count, attainment of first CR within 48 days, type of reinduction treatment, and the cerebral spinal fluid (CSF) blast count at the time of relapse, have a less important, but nevertheless significant influence on survival. The median survival from the time of CNS relapse is 25 months, the 5-year survival is 25%, whereas the ultimate survival will be less than 20%. From 90 patients who developed second or subsequent relapses, 75% experienced a bone marrow relapse during the follow-up period. From this study the authors conclude that CNS relapse in children with ALL carries a grave prognosis, which requires the institution of intensive retreatment programs. 相似文献
7.
Elke Wezenberg Robert Jan Verkes Ge S F Ruigt Wouter Hulstijn Bernard G C Sabbe 《Neuropsychopharmacology》2007,32(6):1272-1283
Ampakines act as positive allosteric modulators of AMPA-type glutamate receptors and facilitate hippocampal long-term potentiation (LTP), a mechanism associated with memory storage and consolidation. The present study investigated the acute effects of farampator, 1-(benzofurazan-5-ylcarbonyl) piperidine, on memory and information processes in healthy elderly volunteers. A double-blind, placebo-controlled, randomized, cross-over study was performed in 16 healthy, elderly volunteers (eight male, eight female; mean age 66.1, SD 4.5 years). All subjects received farampator (500 mg) and placebo. Testing took place 1 h after drug intake, which was around Tmax for farampator. Subjects performed tasks assessing episodic memory (wordlist learning and picture memory), working and short-term memory (N-back, symbol recall) and motor learning (maze task, pursuit rotor). Information processing was assessed with a tangled lines task, the symbol digit substitution test (SDST) and the continuous trail making test (CTMT). Farampator (500 mg) unequivocally improved short-term memory but appeared to impair episodic memory. Furthermore, it tended to decrease the number of switching errors in the CTMT. Drug-induced side effects (SEs) included headache, somnolence and nausea. Subjects with SEs had significantly higher plasma levels of farampator than subjects without SEs. Additional analyses revealed that in the farampator condition the group without SEs showed a significantly superior memory performance relative to the group with SEs. The positive results on short-term memory and the favorable trends in the trail making test (CTMT) are interesting in view of the development of ampakines in the treatment of Alzheimer's disease and schizophrenia. 相似文献
8.
9.
10.